Matches in Wikidata for { <http://www.wikidata.org/entity/Q37143213> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- Q37143213 description "2008 թվականի դեկտեմբերի 11-ին հրատարակված գիտական հոդված" @default.
- Q37143213 description "article científic" @default.
- Q37143213 description "article scientifique" @default.
- Q37143213 description "articolo scientifico" @default.
- Q37143213 description "artigo científico" @default.
- Q37143213 description "artículu científicu espublizáu en 2008" @default.
- Q37143213 description "bilimsel makale" @default.
- Q37143213 description "scientific article published on 11 December 2008" @default.
- Q37143213 description "vedecký článok" @default.
- Q37143213 description "vetenskaplig artikel" @default.
- Q37143213 description "videnskabelig artikel" @default.
- Q37143213 description "vědecký článek" @default.
- Q37143213 description "wetenschappelijk artikel" @default.
- Q37143213 description "wissenschaftlicher Artikel" @default.
- Q37143213 description "наукова стаття, опублікована в грудні 2008" @default.
- Q37143213 description "научни чланак" @default.
- Q37143213 description "مقالة علمية نشرت في 11 ديسمبر 2008" @default.
- Q37143213 name "A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy" @default.
- Q37143213 name "A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy" @default.
- Q37143213 name "A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy" @default.
- Q37143213 type Item @default.
- Q37143213 label "A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy" @default.
- Q37143213 label "A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy" @default.
- Q37143213 label "A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy" @default.
- Q37143213 prefLabel "A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy" @default.
- Q37143213 prefLabel "A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy" @default.
- Q37143213 prefLabel "A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy" @default.
- Q37143213 P1433 Q37143213-8B8BD846-268F-463A-8093-5287C5AAE246 @default.
- Q37143213 P1476 Q37143213-E5DBF413-8A7A-45F2-9C1B-B869F5E43F40 @default.
- Q37143213 P2093 Q37143213-128ABB4D-1A20-4C7B-8652-71BC34788872 @default.
- Q37143213 P2093 Q37143213-4E170CFB-ECCA-4002-9A2B-6E7AC1BA4DD4 @default.
- Q37143213 P2093 Q37143213-7114820C-A84F-464F-8E47-ED0BA14F2D22 @default.
- Q37143213 P2860 Q37143213-18FFD511-66AB-4A1E-A546-DB55E642D71D @default.
- Q37143213 P2860 Q37143213-1D1FBB1F-7F3C-4C9B-BED3-CE2E047F54EB @default.
- Q37143213 P2860 Q37143213-2761A846-4433-47B0-83FE-892AA95F8B16 @default.
- Q37143213 P2860 Q37143213-3756BAF7-2D1C-49C3-9F89-04E9F25816D0 @default.
- Q37143213 P2860 Q37143213-3D24CCF6-7C28-4524-B271-E7A89EA8200A @default.
- Q37143213 P2860 Q37143213-42074149-2E71-401D-8FE1-47157D0DF2EE @default.
- Q37143213 P2860 Q37143213-4F0BD2A0-E03B-4221-9C48-D1384B80287B @default.
- Q37143213 P2860 Q37143213-68CFB7C6-EB25-49FA-8D78-BBF1ECB07497 @default.
- Q37143213 P2860 Q37143213-AF7AE8C9-441B-4983-AC49-CC77C71FBA33 @default.
- Q37143213 P2860 Q37143213-B04F8BDF-6692-4F37-B3F5-14AA2BC9CB2B @default.
- Q37143213 P2860 Q37143213-B74FA148-0D71-4598-9A08-E2E490F62936 @default.
- Q37143213 P2860 Q37143213-E13BE45C-EB47-4D7A-A417-F8CACCEC5333 @default.
- Q37143213 P2860 Q37143213-E341F602-A42E-453B-AD43-EFCCEC47EE69 @default.
- Q37143213 P304 Q37143213-FCD2FEAC-89FE-44F3-BC71-E5FD9CA9BC70 @default.
- Q37143213 P31 Q37143213-D543942F-8242-4F54-8E72-3B9F04F775A4 @default.
- Q37143213 P356 Q37143213-B4966C87-8722-483F-B881-6AEC2CE35362 @default.
- Q37143213 P433 Q37143213-7B8820C1-CCDA-4E12-8776-9555EDDDCA84 @default.
- Q37143213 P478 Q37143213-FE87B3C6-7DF8-4266-B478-2BC932E51E65 @default.
- Q37143213 P577 Q37143213-1581ABD8-4978-43B5-9EAF-A76659BC28E3 @default.
- Q37143213 P5875 Q37143213-27FF6949-E8A7-4A99-8C9C-E2791A9CDE5D @default.
- Q37143213 P698 Q37143213-3B266ABD-2D08-48CF-A248-E379A0BC18F1 @default.
- Q37143213 P921 Q37143213-82045932-CA13-4D2E-99B6-5E6175E56199 @default.
- Q37143213 P932 Q37143213-4F8FF7AE-A536-4CD9-92BE-E08015A2DE58 @default.
- Q37143213 P356 J.BCMD.2008.10.011 @default.
- Q37143213 P698 19083245 @default.
- Q37143213 P1433 Q15758051 @default.
- Q37143213 P1476 "A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy" @default.
- Q37143213 P2093 "J A Blaisdell" @default.
- Q37143213 P2093 "J A Goldstein" @default.
- Q37143213 P2093 "N A Limdi" @default.
- Q37143213 P2860 Q27641685 @default.
- Q37143213 P2860 Q34735686 @default.
- Q37143213 P2860 Q37195550 @default.
- Q37143213 P2860 Q37372721 @default.
- Q37143213 P2860 Q37376879 @default.
- Q37143213 P2860 Q43675710 @default.
- Q37143213 P2860 Q43705897 @default.
- Q37143213 P2860 Q43820514 @default.
- Q37143213 P2860 Q43942672 @default.
- Q37143213 P2860 Q45000637 @default.
- Q37143213 P2860 Q67728153 @default.
- Q37143213 P2860 Q73597352 @default.
- Q37143213 P2860 Q83203029 @default.
- Q37143213 P304 "155-158" @default.
- Q37143213 P31 Q13442814 @default.
- Q37143213 P356 "10.1016/J.BCMD.2008.10.011" @default.
- Q37143213 P433 "2" @default.
- Q37143213 P478 "42" @default.
- Q37143213 P577 "2008-12-11T00:00:00Z" @default.
- Q37143213 P5875 "23664051" @default.
- Q37143213 P698 "19083245" @default.
- Q37143213 P921 Q407431 @default.
- Q37143213 P932 "2662477" @default.